Delphine Poncet
Papers
2
Total Citations
57
H-Index
2
About
Delphine Poncet is a leading urologic surgeon and researcher whose work centers on refining surgical techniques for kidney cancer, particularly through robotic-assisted partial nephrectomy. Her primary research focus is the delicate balance between oncologic control and renal function preservation, with a specific emphasis on minimizing ischemia-related damage to healthy kidney tissue during tumor resection. Poncet’s major contributions include pioneering investigations into superselective ischemia—a technique that clamps only the tumor-specific segmental artery rather than the main renal artery. Her landmark randomized controlled trial, the EMERALD study (2021, 32 citations), demonstrated that superselective clamping does not yield superior long-term renal function compared to standard renal artery clamping, challenging a widely held assumption and directly influencing surgical decision-making. Earlier prospective matched-pair analyses (2018, 25 citations) comparing superselective clamping with early-unclamping techniques further clarified the trade-offs between ischemic injury and surgical risk. Through rigorous comparative effectiveness research, Poncet has provided essential evidence that helps surgeons weigh the theoretical benefits of super-selective techniques against their practical limitations, ultimately guiding more informed, patient-centered approaches in nephron-sparing surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2